Detalhe da pesquisa
1.
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
N Engl J Med
; 390(22): 2047-2060, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865660
2.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
3.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635762
4.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
5.
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Blood
; 141(22): 2727-2737, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857637
6.
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Blood
; 141(19): 2307-2315, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821768
7.
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Haematologica
; 109(3): 777-786, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731379
8.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504387
9.
Management of post-autologous transplant relapse in patients with T-cell lymphomas.
Am J Hematol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661220
10.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
11.
Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.
Mod Pathol
; 36(10): 100256, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391168
12.
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.
Blood
; 137(17): 2321-2325, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512414
13.
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.
Blood
; 135(1): 28-40, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697815
14.
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.
Blood
; 133(1): 94-99, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279226
15.
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 26(12): e328-e332, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961371
16.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
N Engl J Med
; 377(26): 2531-2544, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226797
17.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(1): 31-42, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518502
18.
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Biol Blood Marrow Transplant
; 25(10): 2002-2007, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260802
19.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446199
20.
Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Am J Transplant
; 19(6): 1820-1830, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30748099